Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.08 - $809.55 $70 - $713,213
-881 Reduced 0.21%
410,484 $35,000
Q2 2022

Aug 12, 2022

BUY
$0.27 - $0.71 $8,236 - $21,659
30,507 Added 8.01%
411,365 $120,000
Q1 2022

May 13, 2022

BUY
$0.38 - $1.07 $4,520 - $12,729
11,897 Added 3.22%
380,858 $269,000
Q3 2021

Nov 12, 2021

BUY
$2.14 - $4.95 $789,576 - $1.83 Million
368,961 New
368,961 $837,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $127M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.